PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022

$0N01FY2004CNNIH

Wayne State University, Detroit MI

Investigators

View original record on NIH RePORTER →